COUMADIN (WARFARIN SODIUM TABLETS, USP) Trademark

Trademark Overview


On Friday, November 4, 2016, a trademark application was filed for COUMADIN (WARFARIN SODIUM TABLETS, USP) with the United States Patent and Trademark Office. The USPTO has given the COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark a serial number of 87226817. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 29, 2023. This trademark is owned by Bristol-Myers Squibb Pharma Company. The COUMADIN (WARFARIN SODIUM TABLETS, USP) trademark is filed in the Pharmaceutical Products category with the following description:

An anticoagulant pharmaceutical preparation
coumadin (warfarin sodium tablets, usp)

General Information


Serial Number87226817
Word MarkCOUMADIN (WARFARIN SODIUM TABLETS, USP)
Filing DateFriday, November 4, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 29, 2023
Registration Number5222641
Registration DateTuesday, June 13, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements


Description of MarkThe mark consists of the words "COUMADIN (WARFARIN SODIUM TABLETS, USP)" in black font and a design of a splash in the colors purple, pink, blue, beige, white and black on a yellow background.
Goods and ServicesAn anticoagulant pharmaceutical preparation
Indication of Colors claimedThe color(s) purple, pink, blue, beige, white, yellow and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"(WARFARIN SODIUM TABLETS, USP)"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateFriday, April 12, 2002
First Use In Commerce DateFriday, April 12, 2002

Trademark Owner History


Party NameBristol-Myers Squibb Pharma Company
Party Type30 - Original Registrant
Legal Entity Type02 - Partnership
AddressPrinceton, NJ 08540

Party NameBristol-Myers Squibb Pharma Company
Party Type20 - Owner at Publication
Legal Entity Type02 - Partnership
AddressPrinceton, NJ 08540

Party NameBristol-Myers Squibb Pharma Company
Party Type10 - Original Applicant
Legal Entity Type02 - Partnership
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Friday, December 29, 2023CANCELLED SEC. 8 (6-YR)
Monday, June 13, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, February 12, 2017ASSIGNED TO EXAMINER
Wednesday, November 9, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 8, 2016NEW APPLICATION ENTERED